Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-9-18
|
pubmed:abstractText |
All of the 88 episodes of beta-haemolytic streptococcal bacteremia (2.9% of all bacteremias) in adult patients during the years 1987-94 in a university hospital were reviewed. 38 bacteremias (43%) were caused by group A, 24 (27%) by group B, 3 (4%) by group C, and 23 (26%) by group G beta-haemolytic streptococcal. There was a statistically significant increase in group A and decrease in group C and G bacteremias (p < 0.02) compared to an earlier 8-year period in the same hospital, although the total number of streptococcal bacteremias remained the same. The most common T types of group A streptococcal strains were T11 (26%), T28 (14%), T6 and T1 (11% each), and T12 (8%). Cardiovascular disease, skin lesions, malignancy, and alcohol abuse were the most common underlying conditions. The most usual types of infection were skin (47%) and respiratory tract infections (23%). The overall mortality was 16%. It was highest in group A (24%) and lowest in group C (0%), 38% of patients with pneumonia died. All streptococcal strains were sensitive to penicillin, vancomycin, and cephalosporins. 11% of group A and 12% of all the strains had decreased sensitivity to erythromycin, 14 and 38% to tetracycline, and 0 and 2% to clindamycin, respectively.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0036-5548
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
233-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9255881-Adolescent,
pubmed-meshheading:9255881-Adult,
pubmed-meshheading:9255881-Aged,
pubmed-meshheading:9255881-Aged, 80 and over,
pubmed-meshheading:9255881-Anti-Bacterial Agents,
pubmed-meshheading:9255881-Bacteremia,
pubmed-meshheading:9255881-Bacterial Typing Techniques,
pubmed-meshheading:9255881-Cardiovascular Diseases,
pubmed-meshheading:9255881-Clindamycin,
pubmed-meshheading:9255881-Drug Resistance, Microbial,
pubmed-meshheading:9255881-Erythromycin,
pubmed-meshheading:9255881-Female,
pubmed-meshheading:9255881-Finland,
pubmed-meshheading:9255881-Humans,
pubmed-meshheading:9255881-Male,
pubmed-meshheading:9255881-Microbial Sensitivity Tests,
pubmed-meshheading:9255881-Middle Aged,
pubmed-meshheading:9255881-Neoplasms,
pubmed-meshheading:9255881-Retrospective Studies,
pubmed-meshheading:9255881-Skin Diseases,
pubmed-meshheading:9255881-Streptococcal Infections,
pubmed-meshheading:9255881-Streptococcus,
pubmed-meshheading:9255881-Streptococcus agalactiae,
pubmed-meshheading:9255881-Streptococcus pyogenes,
pubmed-meshheading:9255881-Tetracycline
|
pubmed:year |
1997
|
pubmed:articleTitle |
A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period.
|
pubmed:affiliation |
Department of Medicine, Helsinki University Central Hospital, Finland.
|
pubmed:publicationType |
Journal Article
|